<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Viral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of secondary bacterial infections and having a significant impact on disease-related morbidity and mortality. Several antivirals such as oseltamivir and zanamivir evaluated in influenza and other virus-induced respiratory infections are discussed in this review as a starting point of their potential use in improving the outcome of asthma and COPD exacerbations. However, the efficacy of antiviral therapy for asthma/COPD exacerbations needs a further evaluation.</p></abstract>

Viral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of secondary bacterial infections and having a significant impact on disease-related morbidity and mortality. Several antivirals such as oseltamivir and zanamivir evaluated in influenza and other virus-induced respiratory infections are discussed in this review as a starting point of their potential use in improving the outcome of asthma and COPD exacerbations. However, the efficacy of antiviral therapy for asthma/COPD exacerbations needs a further evaluation.

Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment

University of Medicine and Pharmacy “Gr. T. Popa”,

University of Medicine and Pharmacy “Carol Davila”

ARS Medica Tomitana

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment"}

Viral respiratory infections in patients with asthma or chronic obstructive pulmonary disease (COPD) can cause severe exacerbations, increasing the risk of...

Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment

Online veröffentlicht: 25. Jan. 2019

Seitenbereich: 152 - 156

DOI: https://doi.org/10.2478/arsm-2018-0027

Schlüsselwörter
antiviral therapy, asthma, COPD, oseltamivir, zanamivir

© 2018 Grigorescu Cristina et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Antivirals for Virus Induced Exacerbations of Asthma and COPD Treatment

Online veröffentlicht: 25. Jan. 2019

Seitenbereich: 152 - 156

DOI: https://doi.org/10.2478/arsm-2018-0027

Schlüsselwörterantiviral therapy, asthma, COPD, oseltamivir, zanamivir

© 2018 Grigorescu Cristina et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
antiviral therapy, asthma, COPD, oseltamivir, zanamivir